Citation Impact
Citing Papers
Ferroptosis regulation by the NGLY1/NFE2L1 pathway
2022 StandoutNobel
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
The relationship between oxygen radical generation and impairment of myocardial energy metabolism following post-ischemic reperfusion,
1991
LTRPC2 Ca2+-Permeable Channel Activated by Changes in Redox Status Confers Susceptibility to Cell Death
2002
International Union of Pharmacology. XLIX. Nomenclature and Structure-Function Relationships of Transient Receptor Potential Channels
2005 StandoutNobel
Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders
2003
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
O2 sensing in hypoxic pulmonary vasoconstriction: the mitochondrial door re-opens
2002
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction
2015
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
1997 StandoutNature
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea
2000
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
2002 StandoutNature
Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis
2001 Standout
Hepatitis B Virus Infection
2008
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Drug-Induced Hepatotoxicity
2003 Standout
Is Z-disk degradation responsible for postmortem tenderization?
1995
Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistance
2002
Hepatitis B virus infection
2009 Standout
HIF-1 and mechanisms of hypoxia sensing
2001 StandoutNobel
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Inflammation and insulin resistance
2006 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
2004 Standout
Metabolic Delivery of Ketone Groups to Sialic Acid Residues
1998 StandoutNobel
TRP channels as cellular sensors
2003 StandoutNature
Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B
2003
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Percutaneous transluminal balloon angioplasty for obstruction of the suprahepatic inferior vena cava and cavo-atrial graft stenosis
1989
AGA technical review on parenteral nutrition
2001
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase
2003
Increased plasma levels of glutathione and malondialdehyde after acute ethanol ingestion in humans
1989
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Alcoholic Liver Disease
1989
Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial
2001
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNobel
Myocardial Reperfusion Injury
2007 Standout
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Glutathione synthesis
2012 Standout
Molecular bases of cellular iron toxicity12 1Guest Editor: Mario Comporti 2This article is part of a series of reviews on “Iron and Cellular Redox Status.” The full list of papers may be found on the homepage of the journal.
2002
Early versus Late Parenteral Nutrition in Critically Ill Adults
2011 Standout
Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials
2003 Standout
Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system
2009
Paracetamol (acetaminophen) poisoning
1993
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
2005 Standout
Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences
1995 StandoutNobel
Liver Biopsy
2001 Standout
Dietary Compensation by Humans for Supplemental Energy Provided as Ethanol or Carbohydrate in Fluids
1996
Energy and protein requirements of patients with chronic liver disease
1997
Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: Potential mechanism for sensitization to liver damage
2000
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
1991 Standout
Improved ion-pair high-performance liquid chromatographic method for the quantification of a wide variety of nucleotides and sugar—nucleotides in animal cells
1991
Chronic Hepatitis B: Current Testing Strategies
2006
Extracellular DNA traps promote thrombosis
2010 Standout
Acetaminophen Hepatotoxicity in Alcoholics
1986
Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients
1996
PTEN Activity Is Modulated During Ischemia and Reperfusion
2005 StandoutNobel
Drug effects on the liver
1983
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Ketone Isosteres of 2-N-Acetamidosugars as Substrates for Metabolic Cell Surface Engineering
2001 StandoutNobel
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
The Calpain System
2003 Standout
Regulation of γ-glutamylcysteine synthetase by protein phosphorylation
1996
Understanding Adipocyte Differentiation
1998 Standout
Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha.
1991
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications
2001
Hydrogen peroxide — an intracellular signal in the pulmonary circulation: involvement in hypoxic pulmonary vasoconstriction
2000
The Hypercoagulable States
1985
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
The Treatment of Acetaminophen Poisoning
1983
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
O 2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase
1999
Molecular and Cellular Mechanisms of Myocardial Stunning
1999
COAGULATION DISORDERS IN CANCER
1996
Hepatic cyclic GMP formation is regulated by similar factors that modulate activation of purified hepatic soluble guanylate cyclase.
1987 StandoutNobel
An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation
1980 StandoutNobel
A redox-based O2 sensor in rat pulmonary vasculature.
1993
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine
2004
Treatment of Chronic Viral Hepatitis
2001
Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome.
1987
Nutritional supplementation in chronic liver disease: An analytical review
1994
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
1996 StandoutScience
Creatine and Creatinine Metabolism
2000 Standout
Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation
2002
Works of Mack C. Mitchell being referenced
Additive protection of cimetidine and N-acetylcysteine treatment against acetaminophen-induced hepatic necrosis in the rat.
1985
Analysis of pyridine dinucleotides in cultured rat hepatocytes by high-performance liquid chromatography
1989
Plasma Tumor Necrosis Factor α Predicts Decreased Long‐Term Survival in Severe Alcoholic Hepatitis
1990
Titin content of beef in relation to tenderness
1993
Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy
1999
Increased hepatic efflux of glutathione after chronic ethanol feeding
1986
Alcohol and Nutrition: Caloric Value, Bioenergetics, and Relationship to Liver Damage
1986
Budd-Chiari Syndrome
1982
Granulomatous hepatitis associated with carbamazepine therapy
1981
Changes in plasma amino acids during sobriety in alcoholic patients with and without liver disease
1986
Progressive Hemochromatotic Cardiomyopathy Despite Reversal of Iron Deposition After Liver Transplantation
1993
Energy state and vasomotor tone in hypoxic pig lungs
1991
Effects of vasopressor hormones and modulators of protein kinase C on glutathione efflux from perfused rat liver
1991
Cimetidine Protects Against Acetaminophen Hepatotoxicity in Rats
1981
Effects of ATP precursors on ATP and free ADP content and functional recovery of postischemic hearts
1989
Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: A randomized controlled trial
1991